Nemirovskiĭ V S, Ostroumova M N, Blagosklonnaia Ia V, Uskova A L, Freĭdlin I S
Vopr Onkol. 1978;24(4):65-8.
Taking into account the conception of metabolic immunosuppression, arising in the case when fatty acids but no glucose serves as the basic energetic substrate, the authors have studied the effect of miscleron (clofibrate, athromid-S) on a number of hormonal-metabolic and immune indices. It is shown that miscleron in addition to decreasing the blood level of cholesterol, beta-lipoproteids, triglycerids, free fatty acids, cortisol and reducing 17-ketosteroids excretion, produces higher indices of the blasttransformation reaction, induced by FHA, an increased phagocytic index of monocytes, a rise in the level of peroxidase and lysosomal activity of monocytes. Miscleron and other substances lowering the lipid level in blood should be examined in patients with nonlymphoid types of tumors both with the aim to eliminate metabolic immunosuppression and to retard the rate of tumor cells growth due to a reduced level of low density lipoproteins.
考虑到当脂肪酸而非葡萄糖作为基本能量底物时出现的代谢性免疫抑制概念,作者研究了安妥明(氯贝丁酯,祛脂乙酯)对一些激素 - 代谢和免疫指标的影响。结果表明,安妥明除了能降低血液中胆固醇、β - 脂蛋白、甘油三酯、游离脂肪酸、皮质醇水平以及减少17 - 酮类固醇排泄外,还能提高由FHA诱导的母细胞转化反应指标,增加单核细胞的吞噬指数,提高单核细胞的过氧化物酶水平和溶酶体活性。对于非淋巴细胞类型肿瘤患者,应检查安妥明和其他降低血液脂质水平的物质,目的是消除代谢性免疫抑制,并由于低密度脂蛋白水平降低而延缓肿瘤细胞生长速度。